Amgen Inc. Stock News

Argus Investors Counsel Inc. lessened its stake in shares of Amgen Inc. (NASDAQ:AMGN) by 34.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,299 shares of the medical research companys stock after selling 5,466 shares during the quarter. Amgen comprises about 1.4% of []

44 Wealth Management LLC grew its position in Amgen Inc. (NASDAQ:AMGN) by 20.0% during the third quarter, Holdings Channel reports. The firm owned 5,279 shares of the medical research companys stock after acquiring an additional 879 shares during the period. 44 Wealth Management LLCs holdings in Amgen were worth $1,123,000 as of its most recent []

"The Dow [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Sector representation is also a consideration."–

THOUSAND OAKS, Calif. , Dec. 3, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $1.94 per share dividend for the first quarter of 2022. The dividend will be paid on March 8, 2022 , to all stockholders of record as of the close of business on February

Vigilare Wealth Management decreased its position in Amgen Inc. (NASDAQ:AMGN) by 16.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,691 shares of the medical research companys stock after selling 334 shares during the quarter. Vigilare Wealth Managements holdings in Amgen were worth []

Dixon Hubard Feinour & Brown Inc. VA raised its position in shares of Amgen Inc. (NASDAQ:AMGN) by 31.6% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,261 shares of the medical research companys stock after purchasing an additional 303 shares during []

Stratos Wealth Advisors LLC lifted its holdings in Amgen Inc. (NASDAQ:AMGN) by 67.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,182 shares of the medical research companys stock after acquiring an additional 2,094 shares during the quarter. Stratos Wealth Advisors LLCs holdings []

Top 10 High Yield Dividend Stocks For December 2021

Oregon Public Employees Retirement Fund trimmed its position in shares of Amgen Inc. (NASDAQ:AMGN) by 3.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 121,695 shares of the medical research companys stock after selling 4,563 shares during the period. []

Albion Financial Group UT lowered its position in Amgen Inc. (NASDAQ:AMGN) by 0.4% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 24,387 shares of the medical research companys stock after selling 110 shares during the quarter. Albion Financial Group UTs holdings in Amgen were []

Amgen (AMGN) reported earnings 30 days ago. What's next for the stock?

This article was originally published on TipRanks.com Amgen (AMGN) has revealed positive topline results from the Phase 3 DISCREET trial. The post Amgen Reveals Topline Results from Otezla Phase 3 DISCREET Study appeared first on Smarter Analyst .

With the spotlight firmly on Covid variants, its easy to lose sight of what will probably be the most important segment of the biopharma space over the next ten years: oncology. This is where the biggest success stories will be found. Its where the largest revolutions will happen. Its the epicenter of the most important [] The post Biotech Growth Stocks Set to Benefit from Rising Volatility (REGN, OTLC, AMGN, ILMN, LLY, GILD, MRK) appeared first on Wall Street PR .